 Masimo Corps NASDAQ: MASI Q4 product revenue increased 11 YY to 327.6 million, or 11.5 on a constant currency basis, beating the consensus of 320.93 million. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 76,000 in the fourth quarter. 